Sun Pharma Advanced Research Company Ltd
About
[
edit
]
Sun Pharma Advanced Research Company is engaged in the business of research & development of pharmaceutical products.
[
add key points
]
- Market Cap ₹ 4,467 Cr.
- Current Price ₹ 170
- High / Low ₹ 210 / 81.0
- Stock P/E
- Book Value ₹ -1.78
- Dividend Yield 0.00 %
- ROCE -182 %
- ROE -230 %
- Face Value ₹ 1.00
Pros
- Company is expected to give good quarter
Cons
- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of -13.18% over past five years.
- Company has a low return on equity of -130.60% for last 3 years.
- Debtor days have increased from 59.49 to 76.27 days.
Peer comparison
Sector: Miscellaneous Industry: Miscellaneous
Loading peers table ...
Quarterly Results
Figures in Rs. Crores
Mar 2018 | Jun 2018 | Sep 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sep 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sep 2020 | Dec 2020 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
20 | 17 | 61 | 20 | 85 | 17 | 17 | 20 | 23 | 185 | 18 | 22 | |
65 | 81 | 67 | 90 | 97 | 112 | 80 | 73 | 121 | 125 | 100 | 85 | |
Operating Profit | -45 | -64 | -5 | -70 | -12 | -95 | -63 | -54 | -98 | 61 | -82 | -63 |
OPM % | -224% | -379% | -8% | -354% | -14% | -549% | -366% | -274% | -433% | 33% | -467% | -289% |
Other Income | 50 | 1 | 5 | 3 | 4 | 4 | 2 | 1 | 3 | 1 | 3 | 2 |
Interest | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 2 | 2 | 1 | 4 |
Depreciation | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 3 | 3 | 3 | 3 |
Profit before tax | 2 | -64 | -3 | -69 | -9 | -94 | -63 | -56 | -100 | 57 | -83 | -68 |
Tax % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
Net Profit | 2 | -64 | -3 | -69 | -9 | -94 | -63 | -56 | -100 | 57 | -83 | -68 |
EPS in Rs | 0.10 | -2.57 | -0.10 | -2.70 | -0.36 | -3.59 | -2.41 | -2.12 | -3.80 | 2.16 | -3.19 | -2.58 |
Notes | Notes | Notes | Notes | Notes | Notes | Notes | Notes | Notes | Notes | Notes | Notes |
Profit & Loss
Figures in Rs. Crores
Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
35 | 34 | 58 | 29 | 87 | 167 | 156 | 161 | 181 | 78 | 183 | 77 | 248 | |
45 | 53 | 65 | 99 | 104 | 134 | 191 | 224 | 304 | 321 | 334 | 387 | 431 | |
Operating Profit | -10 | -19 | -7 | -70 | -17 | 34 | -35 | -63 | -123 | -243 | -151 | -310 | -183 |
OPM % | -29% | -56% | -11% | -241% | -19% | 20% | -23% | -39% | -68% | -310% | -83% | -404% | -74% |
Other Income | -0 | 0 | 1 | 1 | 2 | 10 | 3 | 3 | 14 | 54 | 14 | 10 | 8 |
Interest | 0 | 0 | 0 | 0 | 4 | 6 | 0 | 2 | 2 | 0 | 0 | 3 | 8 |
Depreciation | 2 | 3 | 3 | 3 | 3 | 4 | 7 | 8 | 8 | 8 | 8 | 9 | 11 |
Profit before tax | -12 | -22 | -8 | -72 | -22 | 34 | -40 | -70 | -119 | -197 | -145 | -312 | -194 |
Tax % | 27% | -0% | 0% | 0% | 0% | 12% | 0% | 0% | 0% | 0% | 0% | 0% | |
Net Profit | -9 | -22 | -8 | -72 | -22 | 30 | -40 | -70 | -119 | -197 | -145 | -312 | -194 |
EPS in Rs | -0.37 | -0.87 | -0.34 | -2.93 | -0.91 | 1.23 | -1.60 | -2.83 | -4.82 | -7.85 | -5.55 | -11.92 | -7.41 |
Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
Compounded Sales Growth | |
---|---|
10 Years: | 8% |
5 Years: | -13% |
3 Years: | -25% |
TTM: | 78% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
TTM: | 13% |
Stock Price CAGR | |
---|---|
10 Years: | 9% |
5 Years: | -10% |
3 Years: | -26% |
1 Year: | 15% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | -128% |
3 Years: | -131% |
Last Year: | -230% |
Balance Sheet
Figures in Rs. Crores
Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Sep 2020 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
21 | 21 | 21 | 21 | 24 | 24 | 24 | 24 | 25 | 25 | 26 | 26 | 26 | |
Reserves | 15 | -7 | -15 | -87 | 85 | 116 | 76 | 6 | 133 | 160 | 270 | -45 | -73 |
Borrowings | 2 | 2 | 7 | 68 | 81 | 5 | 4 | 56 | 3 | 2 | 2 | 68 | 106 |
24 | 56 | 66 | 84 | 20 | 39 | 39 | 77 | 111 | 122 | 101 | 223 | 191 | |
Total Liabilities | 62 | 72 | 78 | 86 | 209 | 184 | 143 | 163 | 273 | 309 | 398 | 273 | 250 |
53 | 61 | 63 | 64 | 66 | 64 | 67 | 70 | 69 | 52 | 58 | 104 | 99 | |
CWIP | 4 | 2 | 1 | 1 | 0 | 1 | 0 | 1 | 1 | 3 | 24 | 32 | 6 |
Investments | 0 | 0 | 2 | 0 | 97 | 6 | 0 | 0 | 10 | 108 | 211 | 8 | 25 |
4 | 9 | 11 | 21 | 46 | 112 | 76 | 92 | 192 | 146 | 106 | 128 | 120 | |
Total Assets | 62 | 72 | 78 | 86 | 209 | 184 | 143 | 163 | 273 | 309 | 398 | 273 | 250 |
Cash Flows
Figures in Rs. Crores
Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
25 | 13 | 2 | -69 | -95 | 37 | -41 | -44 | -128 | -183 | -172 | -211 | |
-26 | -12 | -8 | -2 | -99 | 44 | 53 | -13 | -7 | -105 | -102 | 155 | |
1 | 0 | 4 | 72 | 194 | -81 | -1 | 51 | 194 | 224 | 274 | 55 | |
Net Cash Flow | 0 | 1 | -1 | 0 | -0 | -0 | 11 | -7 | 60 | -63 | 0 | 0 |
Ratios
Figures in Rs. Crores
Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
ROCE % | -29% | -79% | -59% | -1,034% | -20% | 21% | -32% | -71% | -95% | -143% | -62% | -182% |
Debtor Days | 5 | 5 | 16 | 54 | 105 | 61 | 47 | 21 | 78 | 82 | 20 | 76 |
Inventory Turnover |
Documents
Add documentRecent announcements
- Update On TACLANTIS™ (Paclitaxel Injection Concentrate For Suspension) NDA 23 Feb
- Update On TACLANTIS™ (Paclitaxel Injection Concentrate For Suspension) NDA 23 Feb
- Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011. 20 Feb
- Outcome Of Board Meeting Held On 8Th February 2021. 8 Feb
- Outcome Of Board Meeting Held On 8Th February 2021. 8 Feb
View all
Annual reports
- Financial Year 2020 from bse
- Financial Year 2019 from bse
- Financial Year 2018 from bse
- Financial Year 2017 from bse
- Financial Year 2016 from bse
- Financial Year 2015 from bse
- Financial Year 2014 from bse
- Financial Year 2013 from bse
- Financial Year 2012 from bse
- Financial Year 2011 from bse
- Financial Year 2011 from nse
- Financial Year 2010 from bse
- Financial Year 2010 from nse